申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150094309A1
公开(公告)日:2015-04-02
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
本公开提供I式化合物及其盐,以及使用该化合物的组合物和方法。该化合物是尼古丁α7受体的配体,可用于治疗中枢神经系统的各种障碍,特别是情感和神经退行性障碍。